Stable α- and β-islet cell function after tolerance induction to pancreatic islet allografts in diabetic primates

American Journal of Transplantation

Volumn 3, Issue 2, 2003, Pages 128-138

  Contreras, Juan L ^a   Jenkins, Stacie ^a   Eckhoff, Devin E ^a   Hubbard, William J ^a   Lobashevsky, Andrew ^a   Bilbao, Guadalupe ^b   Thomas, Francis T ^a   Neville Jr , David M ^a   Thomas, Judith M ^a  

^a Kentucky   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Islet mass; Islet transplantation; Primates; Tolerance

Indexed keywords

15 DEOXYSPERGUALIN; ANTIBODY CONJUGATE; IMMUNOGLOBULIN F(AB) FRAGMENT; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY CD3;

ACUTE GRAFT REJECTION; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL METABOLISM; CONTROLLED STUDY; GLUCOSE CLAMP TECHNIQUE; HYPERGLYCEMIA; IMMUNOLOGICAL TOLERANCE; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS FUNCTION; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIMATE; RHESUS MONKEY; STREPTOZOCIN DIABETES;

ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TOLERANCE TEST; GRAFT REJECTION; GUANIDINES; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; MACACA MULATTA; MALE; REFERENCE VALUES; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

EID: 0037298315     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00031.x     Document Type: Article

References (39)

1. Hering BJ, Ricordi C. Islet transplantation for patients with type I diabetes. Graft 1999; 2: 12-27.
2. Weir GC, Bonner-Weir S. Scientific and political impediments to successful islet transplantation. Diabetes 1997; 46: 1247-1256.
3. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
4. Ryan EA, Lakey JR, Rajotte RV et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50: 710-719.
5. Jindal RM, Sidner RA, Milgrom ML. Post-transplant diabetes mellitus. The role of immunosuppression. Drug Saf 1997; 16: 242-257.
6. Luzi L. Metabolic strategies to predict and improve intrahepatic islet graft function. J Mol Med 1999; 77: 49-76.
7. Hubbard WJ, Contreras JL, Eckhoff DE, Thomas FT, Neville D, Thomas JM. Immunotoxins and tolerance induction in primates. Curr Opin Organ Transplant 2000; 5: 29-34.
8. Kirk AD. Transplantation tolerance: a look at the nonhuman primate literature in the light of modern tolerance theories. Crit Rev Immunol 1999; 19: 349-388.
9. Contreras JL, Wang PX, Eckhoff DE et al. Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control. Transplantation 1998; 65: 1159-1169.
10. Thomas JM, Neville DM, Contreras JL et al. Preclinical studies of allograft tolerance in rhesus monkeys: a novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts. Transplantation 1997; 64:124-135.
11. Thomas JM, Contreras JL, Jiang XL et al. Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 1999; 68: 1660-1673.
12. Thomas JM, Eckhoff DE, Contreras JL et al. Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy. Transplantation 2000; 69: 2497-2503.
13. Contreras JL, Eckhoff DE, Cartner S et al. Long-term functional islet mass and metabolic function after xenoislet transplantation in primates. Transplantation 2000; 69: 195-201.
14. Thomas FT, Ricordi C, Contreras JL et al. Reversal of naturally occurring diabetes in primates by unmodified islet xenografts without chronic immunosuppression. Transplantation 1999; 67: 846-854.
15. Kleinbaum J, Shamoon H. Impaired counterregulation of hypoglycemia in insulin-dependent diabetes mellitus. Diabetes 1983; 32: 493-507.
16. Paty BW, Lanz K, Kendall D, Sutherland DER, Robertson P. Restored hypoglycemic counterregulation is stable in successful pancreas transplant recipients for up to 19 years after transplantation. Transplantation 2001; 72: 1103-1107.
17. Thomas JM, Contreras JL, Smyth CA et al. Successful reversal of streptozotocin-induced diabetes with stable allogeneic islet function in a pre-clinical model of IDDM. Diabetes 2001; 50: 1227-1236.
18. Theriault BR, Thistlethwaite JR, Levisetti MG et al. Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis). Transplantation 1999; 68: 331-337.
19. Lobashevsky A, Smith JP, Kasten-Jolly J et al. Identification of DRB alleles in rhesus monkeys using polymerase chain reaction-sequence-specific primers (PCR-SSP) amplification. Tissue Antigens 1999; 54: 254-263.
20. Lobashevsky AL, Thomas JM. Six mamu-A locus alleles defined by a polymerase chain reaction sequence specific primer method. Hum Immunol 2000; 61: 1013-1020.
21. Hansen BC, Bodkin NL. Standardization of IVGTT. Importance of method used to calculate glucose disappearance. Diabetes Care 1993; 16: 847-852.
22. Hansen BC, Bodkin NL. Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey. Diabetologia 1986; 29: 713-719.
23. Unger RH, Foster DW. Diabetes mellitus. In: Wilson, JD, Foster, DW, Kronenberg, HM, Larsen, PR, eds. Williams Textbook of Endocrinology. Philadelphia: Saunders; 1998. p. 973.
24. Teuscher AU, Kendall DM, Smets YF, Leone JP, Sutherland DE, Robertson RP. Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes 1998; 47: 324-330.
25. Kandall DM, Rooney DP, Smets YFC, Bolding LS, Robertson RP. Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in with long-standing type 1 diabetes and autonomic neuropathy. Diabetes 1997; 46: 249-256.
26. Kaufman DB, Gores PF, Field MJ et al. Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass. Diabetes 1994; 43: 778-783.
27. Thomas FT, Tepper MA, Thomas JM, Haisch CE. 15-Deoxyspergualin: a novel immunosuppressive drug with clinical potential. Ann N Y Acad Sci 1993; 685: 175-186.
28. Elmer DS, Hathaway DK, Shokouh-Amiri H, Hughes T, Gaber AO. The relationship of glucose disappearance rate (kG) to acute pancreas allograft rejection. Transplantation 1994; 57: 1400-1405.
29. Elmer DS, Hathaway DK, Bashar AA et al. Use of glucose disappearance rates (kG) to monitor endocrine function of pancreas allografts. Clin Transplant 1998; 12: 56-64.
30. Shapiro AMJ, Hao EG, Lakey JRT et al. Novel approaches toward early diagnosis of islet allograft rejection. Transplantation 2001; 71: 1709-1718.
31. Alejandro R, Lehmann R, Ricordi C et al. Long-term function (6 years) of islet allografts in type 1 diabetes. Diabetes 1997; 46: 1983-1989.
32. Jindal RM, Fineberg SE, Sherman S et al. Clinical experience with autologous and allogeneic pancreatic islet transplantation. Transplantation 1998; 66: 1836-1841.
33. Kenyon NS, Chatzipetrou M, Masetti M et al. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci USA 1999; 96: 8132-8137.
34. Adams AB, Shirasugi N, Durham MM et al. Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates. Diabetes 2002; 51: 265-270.
35. Levisetti MG, Padrid PA, Szot GL et al. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. J Immunol 1997; 159: 5187-5191.
36. Bertuzzi F, Grohovaz F, Maffi P et al. Successful transplantation of human islets in recipients bearing a kidney graft. Diabetologia 2002;45:77-84.
37. Teuscher AU, Seaquist ER, Robertson RP. Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients. Diabetes 1994; 43: 593-598.
38. Karam J. Diabetes mellitus. In: Greenspan, FS, Stewlet, G, eds. Basic and Clinical Endocrinology. Stamford, Conn: Prentice Hall International; 1997. p. 618.
39. Contreras JL, Eckhoff DE, Cartner S et al. Tolerability and side effects of anti-CD3-immunotoxin in preclinical testing in kidney and pancreatic islet transplant recipients. Transplantation 1999; 68: 215-219.